Liver Diseases pp 503-512 | Cite as

Dynamic Contrast-Enhanced Ultrasonography of the Liver

  • Laura Iliescu


Contrast-enhanced ultrasonography is a relatively new imaging technique that can be successfully used for the diagnosis and surveillance of liver lesions, among other important roles. The real-time examination possibility and its excellent safety profile represent unique features that make this procedure a highly valuable one. As this technique becomes more widely available, it is of extreme importance that specialists in the field of hepatology understand its clinical applications and capabilities, as well as its disadvantages and limitations. This chapter aims to provide a basic understanding of contrast-enhanced ultrasonography, focusing on its applications in liver imaging.


Contrast-enhanced ultrasonography Benign tumors of the liver Hepatocellular carcinoma Portal vein thrombosis 


  1. 1.
    Wilson SR, Greenbaum LD, Goldberg BB. Contrast-enhanced ultrasound: what is the evidence and what are the obstacles? Am J Roentgenol. 2009;193:55–60. Scholar
  2. 2.
    Jo PC, Jang HJ, Burns PN, Burak KW, Kim TK, Wilson SR. Integration of contrast-enhanced US into a multimodality approach to imaging of nodules in a cirrhotic liver: how I do it. Radiology. 2017;282(2):317–31.CrossRefGoogle Scholar
  3. 3.
    Chung YE, Kim KW. Contrast-enhanced ultrasonography: advance and current status in abdominal imaging. Ultrasonography. 2014;34:3–18.CrossRefGoogle Scholar
  4. 4.
    SonoVue. Assessment Report. European Medicines Agency; 2017.Google Scholar
  5. 5.
    Park JH, et al. Contrast-enhanced US with Perfluorobutane (Sonazoid) used as a surveillance test for hepatocellular carcinoma (HCC) in cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trial. BMC Cancer. 2017;17(1):279. Scholar
  6. 6.
    Zhang XY, et al. Contrast-enhanced ultrasound: improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment. World J Gastroenterol. 2014;20(35):12628–36.CrossRefGoogle Scholar
  7. 7.
    Kim TK, et al. Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 - a review of important differences compared to the CT/MRI system. Clin Mol Hepatol. 2017;23(4):280–9.CrossRefGoogle Scholar
  8. 8.
    Claudon M, Dietrich CF, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver – update 2012 a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall in Med. 2013;34:11–29.CrossRefGoogle Scholar
  9. 9.
    ter Haar G. Safety and bio-effects of ultrasound contrast agents. Med Biol Eng Comput. 2009;47:893–900.CrossRefGoogle Scholar
  10. 10.
    Dietrich CF, Averkiou M, Nielsen MB, et al. How to perform contrast-enhanced ultrasound (CEUS). Ultrasound Int Open. 2018;4(1):E2–E15.CrossRefGoogle Scholar
  11. 11.
    Ferraioli G, Franca Meloni M. Contrast-enhanced ultrasonography of the liver using SonoVue. Ultrasonography. 2018;37(1):25–35. Scholar
  12. 12.
    Yanagisawa K, Moriyasu F, Miyahara T, et al. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol. 2007;33:318–25.CrossRefGoogle Scholar
  13. 13.
    Friedrich-Rust M, Klopffleisch T, Nierhoff J, Herrmann E, Vermehren J, Schneider MD, et al. Contrast-enhanced ultrasound for the differentiation of benign and malignant focal liver lesions: a metaanalysis. Liver Int. 2013;33:739–55.CrossRefGoogle Scholar
  14. 14.
    Xie L, Guang Y, Ding H, Cai A, Huang Y. Diagnostic value of contrast-enhanced ultrasound, computed tomography and magnetic resonance imaging for focal liver lesions: a meta-analysis. Ultrasound Med Biol. 2011;37:854–61.CrossRefGoogle Scholar
  15. 15.
    Quaia E, De Paoli L, Angileri R, Cabibbo B, Cova MA. Indeterminate solid hepatic lesions identified on non-diagnostic contrast-enhanced computed tomography: assessment of the additional diagnostic value of contrast-enhanced ultrasound in the noncirrhotic liver. Eur J Radiol. 2014;83:456–62.CrossRefGoogle Scholar
  16. 16.
    Chernyak V, Santillan CS, Papadatos D, Sirlin CB. LI-RADS(R) algorithm: CT and MRI. Abdom Radiol. 2018;43(1):111–26.CrossRefGoogle Scholar
  17. 17.
    Piscaglia F, Wilson SR, Lyshchik A, Cosgrove D, Dietrich CF, Jang HJ, et al. American College of Radiology contrast enhanced ultrasound liver imaging reporting and data system (CEUS LI-RADS) for the diagnosis of hepatocellular carcinoma: a pictorial essay. Ultraschall Med. 2017;38:320–4.CrossRefGoogle Scholar
  18. 18.
    Badea R, Ioanitescu S. Contrast-enhanced ultrasonography (CEUS) of liver masses—principles, clinical applications, drawbacks. Liver Tumors Epidemiol Diagn Prev Treat. 2013; Scholar
  19. 19.
    Thakur S, Jhobta A, Dhiman DS, Sood RG, Chauhan A, Thakur CS. Role of contrast enhanced ultrasound in characterization of focal liver lesions. Egyptian J Radiol Nucl Med. 2014;45:7–17.CrossRefGoogle Scholar
  20. 20.
    Kim TK, Jang HJ. Contrast-enhanced ultrasound in the diagnosis of nodules in liver cirrhosis. World J Gastroenterol. 2014;20(13):3590–6.CrossRefGoogle Scholar
  21. 21.
    Kunze G, Staritz M, Köhler M. Contrast-enhanced ultrasound in different stages of pyogenic liver abscess. Ultrasound Med Biol. 2015;41:952–9.CrossRefGoogle Scholar
  22. 22.
    Lantinga MA, Gevers TJ, Drenth JP. Evaluation of hepatic cystic lesions. World J Gastroenterol. 2013;19(23):3543–54.CrossRefGoogle Scholar
  23. 23.
    Margini C, Berzigotti A, et al. Portal vein thrombosis: the role of imaging in the clinical setting. Dig Liver Dis. 2017;49(2):113–20.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Laura Iliescu
    • 1
  1. 1.Internal Medicine and Gastroenterology, Institutul Clinic FundeniUniversity of Medicine and Pharmacy (UMF) Carol DavilaBucharestRomania

Personalised recommendations